October’s SHOW will set the stage for an exciting conversation on the world of nanotechnology and its application in bio-medicine. 

Our panel of innovators and thought leaders will share their insights and experiences, spanning academia and industry, on nanotechnology at the crossroads of science and medicine.

Panel Presenters:

• Omar A. Ali, Ph.D.: As a Ph.D. student, Dr. Ali created macroporous polymers that can present a variety of adjuvants with temporal control to finely tune the specificity and magnitude of an immune response. In 2013, in collaboration with scientists at the Wyss Institute and Dana Farber Cancer Institute, he helped translate the first material-based cancer vaccine into clinical testing in melanoma patients.
• Robert Farra, M.S. Mechanical Engineering: Mr. Farra has more than two decades of leadership experience successfully developing complex electro-mechanical and fluidic-based medical devices and combination products. Currently, he serves as the President and Chief Operating Officer of MicroChips Inc., pioneering the next generation of drug delivery and biosensing. Mr. Farra is the named inventor on numerous domestic and international patents issued or pending.
• Elisabet de los Pinos, Ph.D./MBA: Dr. de los Pinos is the founder and CEO of Aura Biosciences which works to develop novel therapeutics using tumor targeted Pseudovirions, a breakthrough technology discovered and patented by Dr. John Schiller at the National Cancer Institute (NCI). Prior to founding Aura, she worked at Eli Lilly’s Oncology Business Unit Unit where she was part of the leadership team responsible for the European market launch of Alimta, a new drug for the treatment of lung cancer.
• Qimin Quan, Ph.D.:Dr. Quann is a junior fellow and principle investigator at Rowland Institute at Harvard University. His lab develops novel optical methods and nanotechnologies to solve biological problems. His recent innovations include the development of CMOS compatible photonic crystal single molecule biosensor, as well as the label-free nano-bioprobe to detect intracellular proteins in single cells

Science Shaping Our World-SHOW is an ongoing seminar and networking series that highlights cutting edge translational life science research and development. Our mission is to bring together a multidisciplinary audience spanning academia and industry providing exposure and insight into the life science advancements changing our world.

Nanotechnology, and its application in science and medicine has been a subject of keen interest and exploration. Yet, much of what constitutes nanotechnology and its true potential are still mired in mystery and the unknown. October’s SHOW will set the stage for an exciting conversation on the world of nanotech and its application in biomedicine. Our panel of innovators and thought leaders will share their insights and experiences, spanning academia and industry. into this exciting new space.

Joining us for October’s SHOW event will be the Nanobiomedicine Journal whose mission is to publish in the areas of nanotechnology as it interfaces biology, as well as its application to the fields of medicine. Nanobiomedicine is an international, peer-reviewed, open access scientific journal with an innovative approach, being open to both the readers and the authors. The journal publishes significant contributions in the cross-disciplinary area intersecting nanotechnology with biomedicine, with particular interest in the applicability of these discoveries and advances.

ee hosaal in